Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Cancer Treat Rev. 2012 Sep 6;39(1):10.1016/j.ctrv.2012.08.001. doi: 10.1016/j.ctrv.2012.08.001

Table 4.

Randomized trials about pharmacologic treatment for delirium

Author Population Size Intervention Results
Edward et al. 94 Delirious patients after hip fracture 16 Donepezil vs placebo No differences regarding presence (odd ratio = 0.9) and severity (effect size = −0.2 on 30-point MDAS) over time.
Tagarakis et al. 95 Delirious patients after cardiac surgery 80 Ondasetron vs haloperidol Effective with no differences between ondasetron (61%) and haloperidol (58%)
Tahir et al.96 General patients with diagnosed delirium 42 Quetiapine vs placebo Quetiapine improved 83% (p = .026) faster than placebo by DRS-R-98 severity
van Eijk et al. 97 Delirious patients diagnosed in intensive care unit 104 Haloperidol rivastigmine Rivastigmine increased mortality (22% vs 5%, p = 0.07) with no decrease duration of delirium
Devlin et al.98 Delirious patients diagnosed in 36 Quetiapine vs placebo Quetiapine added to as-needed haloperidol results in faster resolution (1 vs 4.5 days, p = 0.001)
Kim et al.84 Delirious patients with mostly malignancy 32 Risperidone vs olanzapine Equally effective (65% vs 73%) with no differences(p = 0.71)
Overshott et al. 99 Various patients with diagnosed delirium 15 Rivastigmine vs placebo No difference in duration of delirium between two group(6.3 vs 9.9 days, p = 0.5)
Hu et al.100 Various patients with diagnosed delirium 175 Haloperidol vs olanzapine vs placebo Effective rates of olanzapine, haloperidol and placebo were 82%, 88%, and 31% (p < 0.01 vs placebo), respectively
Breitbart et al. 101 Hospitalized AIDS patients with delirium 30 Haloperidol vs chlorpromazine vs lorazepam DRS scores improved significantly in haloperidol and chlorpromazine (p < 0.001) but not in lorazepam
Grover et al.102 Various patients with delirium 64 Haloperidol vs olanzapine vs risperidone Significant (p < 0.001) reduction in severity scores but no differences between agents
Han et al.103 Various patients with delirium 28 Haloperidol vs risperidone No significant difference in the mean MDAS scores between the two groups (p = 0.51)

DRS, Delirium Rating Scale; DRS R-98, Delirium Rating Scale Revised; MDAS, Memorial Delirium Assessment Scale